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Introduction {#add13320-sec-0005}
============

Electronic cigarettes (e‐cigarettes) have become increasingly popular in recent years, [1](#add13320-bib-0001){ref-type="ref"}, [2](#add13320-bib-0002){ref-type="ref"} and are broadly considered to be less harmful than tobacco. However, the specific risks of e‐cigarette use and exposure are uncertain [3](#add13320-bib-0003){ref-type="ref"}, and e‐cigarette regulation is hotly debated [4](#add13320-bib-0004){ref-type="ref"}, [5](#add13320-bib-0005){ref-type="ref"}. Some regard e‐cigarettes as useful tobacco cessation tools [6](#add13320-bib-0006){ref-type="ref"}, [7](#add13320-bib-0007){ref-type="ref"}, but concerns about negative impacts persist [8](#add13320-bib-0008){ref-type="ref"}, [9](#add13320-bib-0009){ref-type="ref"}. In addition to direct harms, fears exist that e‐cigarettes may reverse progress in de‐normalizing smoking [10](#add13320-bib-0010){ref-type="ref"} and stimulate tobacco use, particularly among young people [11](#add13320-bib-0011){ref-type="ref"}.

In the United Kingdom, e‐cigarette products containing less than 20 mg of nicotine will be subject to various restrictions under the revised European Union Tobacco Products Directive (EU TPD) [12](#add13320-bib-0012){ref-type="ref"} from May 2016, while those containing more than 20 mg, or making medical claims, will need to be licensed as medicines by the Medicines and Healthcare Products Regulatory Agency to be sold. The Scottish Government, UK Department of Health and Welsh Government intend to introduce age‐of‐sale restrictions and bans on proxy purchasing [13](#add13320-bib-0013){ref-type="ref"}, [14](#add13320-bib-0014){ref-type="ref"}. Additionally, the Scottish Government plans to introduce restrictions on domestic e‐cigarette marketing, a register of e‐cigarette retailers, an age‐verification policy, a requirement to formally authorize under‐18s to sell e‐cigarettes and restrictions on domestic e‐cigarette marketing [13](#add13320-bib-0013){ref-type="ref"}, [15](#add13320-bib-0015){ref-type="ref"}.

E‐cigarettes have attracted media attention [16](#add13320-bib-0016){ref-type="ref"}. Policymakers can be influenced by mass media coverage of public interest stories [17](#add13320-bib-0017){ref-type="ref"} as well as public opinion [18](#add13320-bib-0018){ref-type="ref"}, and media content can demonstrably influence public understandings and opinions [19](#add13320-bib-0019){ref-type="ref"}, [20](#add13320-bib-0020){ref-type="ref"}, [21](#add13320-bib-0021){ref-type="ref"}, [22](#add13320-bib-0022){ref-type="ref"}, [23](#add13320-bib-0023){ref-type="ref"}. Stakeholders can attempt to exert influence over public and political attitudes by engaging with media coverage of policy debates [24](#add13320-bib-0024){ref-type="ref"}. Therefore, studying media debates about policy can increase understanding of how stakeholders and their positions are represented, which can help to inform advocacy in future debates in the United Kingdom and elsewhere. This content analysis study examines how stakeholders\' positions on e‐cigarette regulation were represented in 2 years of UK newsprint media coverage.

Methods {#add13320-sec-0006}
=======

A time‐period of 1 January 2013 to 31 December 2014 was chosen to include the publication of the Scottish Government\'s Tobacco Control Strategy [25](#add13320-bib-0025){ref-type="ref"} in March 2013 and the commencement of consultations on e‐cigarette regulation by the UK, Welsh [26](#add13320-bib-0026){ref-type="ref"} and Scottish Governments in late 2014 [27](#add13320-bib-0027){ref-type="ref"}. The purposive sampling frame included eight UK and three Scottish national newspapers from the tabloid, middle‐market tabloid and quality genres [28](#add13320-bib-0028){ref-type="ref"}, [29](#add13320-bib-0029){ref-type="ref"}, [30](#add13320-bib-0030){ref-type="ref"} to ensure that a diverse range of readership profiles was represented [31](#add13320-bib-0031){ref-type="ref"}. Each publication\'s Sunday counterpart was included, excluding the *Sun on* *Sunday*, which is not archived in the Nexis database.

The Nexis database was searched for articles containing three or more hits for the search term 'e‐cig OR (electronic AND cigarette!) OR vape! OR vaping', returning 738 articles. Each article was read and 634 were excluded on the basis of: not mentioning e‐cigarette regulation; being published in the television review, sports, travel, weather or readers\' letters sections of newspapers; or being a duplicate. Following filtering, the sample comprised 104 articles.

The analytical aims were to establish: (1) how frequently different stakeholder categories were cited; (2) how frequently different stakeholder categories were associated with support for, or opposition to, different forms of e‐cigarette regulation; (3) what rationales were used to justify arguments about e‐cigarette regulation, and how frequently; and (4) which specific regulatory positions those corresponded with. Quantitative analysis was used to address the first three aims, while thematic qualitative analysis [32](#add13320-bib-0032){ref-type="ref"} was used to address the fourth. Each article was double‐coded by H.W. and C.P. Researchers coded over‐arching themes based on the codes assigned to the data, discussing differences in coding and interpretation of themes to reach consensus. Themes included the regulation of minimum age of purchase, marketing, e‐cigarette use in enclosed public spaces and e‐cigarettes as medicines.

To collect quantitative data, citations (either direct quotations or indirect mentions) of stakeholders were recorded. Tallies were kept of: how frequently each stakeholder was cited; how frequently they were presented as supporting or opposing regulation in general; how frequently they were presented as supporting or opposing each specific regulatory measure; and how frequently they were associated with specific rationales for their arguments. A multi‐level regression model was used to examine the rate of publication per quarter. To chart the frequency of citations of stakeholder groups against their stances towards regulation, an index was developed to reflect how consistently each stakeholder category was associated with support for regulation. The index expresses the proportion of all positive and negative arguments associated with a stakeholder that were in favour of regulation as a value on a linear scale from −1 (0% supportive) to 1 (100% supportive).

Results {#add13320-sec-0007}
=======

Sample overview {#add13320-sec-0008}
---------------

The sample publications published 104 articles covering e‐cigarette regulation in 2013 (*n* = 28) and 2014 (*n* = 76), representing a mean of 4.7 articles per publication, per year ([Supporting information, Table S1](#add13320-supitem-0002){ref-type="supplementary-material"}). Fifty‐five were published in quality genre publications, 28 in tabloids and 21 in middle‐market tabloids. Three‐quarters were published in UK publications (*n* = 76). A multi‐level regression model indicated that the rate of publication per quarter increased over time (*P* \< 0.001), with a peak of 33 articles in Q4 2014 (Supporting information, Figure [S1](#add13320-supitem-0001){ref-type="supplementary-material"}).

Stakeholder categories {#add13320-sec-0009}
----------------------

Stakeholders were categorized by organizational affiliation (Table [1](#add13320-tbl-0001){ref-type="table-wrap"}). The most frequently cited groups were governmental and regulatory bodies (*n* = 50), politicians (*n* = 20), health charities (*n* = 18) and the e‐cigarette industry (*n* = 15). The most frequently cited individual stakeholders were the World Health Organization (WHO, *n* = 14), Scottish Government (*n* = 12), UK Government (*n* = 10) and the health charities Action on Smoking and Health (ASH) (*n* = 8) and ASH Scotland (*n* = 8).

###### 

Frequency of arguments for specific regulatory measures by stakeholder category.

  Type of regulation                                       *Government & regulatory bodies*   *Bodies representing health professionals*   *Health charities*   *Politicians*   *E‐cigarette industry*   *Academics*   *Total*
  ------------------------------------------------------- ---------------------------------- -------------------------------------------- -------------------- --------------- ------------------------ ------------- ---------
  Regulation of minimum purchasing age                                    11                                      4                                4                  2                   4                   0          25
  Regulation of marketing, advertising and promotion                      16                                      3                                3                  1                   0                   1          24
  Prohibition of e‐cigarettes in enclosed public spaces                   11                                      4                                1                  1                   0                   0          17
  Regulation of e‐cigarettes as medicine                                  11                                      1                                2                  1                   1                   1          17
  Prohibition of proxy purchasing                                         1                                       0                                0                  0                   0                   0           1
  Total                                                                   50                                      12                               10                 5                   5                   2          84

Stakeholders were distributed along a continuum ranging from strong support for, and strong opposition to, e‐cigarette regulation (Fig. [1](#add13320-fig-0001){ref-type="fig"}). Governments, regulatory bodies and bodies representing health professionals almost uniformly supported regulation, while the smokers\' rights group FOREST (Freedom Organization for the Right to Enjoy Smoking Tobacco) consistently opposed regulation, albeit in just two citations. Politicians, health charities, manufacturers of e‐cigarettes and academics were associated with a range of arguments for and against e‐cigarette regulation.

![Frequency of citations of stakeholder categories and their aggregate stance towards regulation (*n* = 104)](ADD-111-1267-g001){#add13320-fig-0001}

E‐cigarette industry sources comprised independent companies and the Electronic Cigarette Industry Trade Association (ECITA), which represents 23 e‐cigarette brands [33](#add13320-bib-0033){ref-type="ref"}. E‐lites, Socialites, Vapestick and Totally Wicked were associated with opposition to regulation, whereas JAC Vapour and Skycig were associated with support. ECITA was associated with equal proportions of arguments for and against regulation. During the sample period, ECITA did not represent any brands owned by transnational tobacco companies (TTCs), and the only TTC‐owned brand cited was Skycig (then owned by RJ Reynolds American, currently owned by Imperial Tobacco under the name Blu), which was cited as supporting age restrictions and regulating e‐cigarettes as medicine.

Political parties\' stances towards regulation corresponded predominantly with their political alignment, consistent with Morley\'s [34](#add13320-bib-0034){ref-type="ref"} observation that pro‐tobacco forces tend to align with the political right. Labour Party, Green Party and Scottish National Party representatives were presented consistently as supportive of regulation, while Conservative Party, Liberal Democrats and UK Independence Party (UKIP) representatives were presented predominantly as opposed.

Stakeholders\' arguments about e‐cigarette regulation {#add13320-sec-0010}
-----------------------------------------------------

Governmental and regulatory bodies (most frequently the WHO, Scottish Government and UK Government), health charities (primarily ASH and ASH Scotland) and bodies representing health professionals \[primarily the British Medical Association (BMA)\] tended to support the introduction of some form of regulation. Three‐quarters (*n* = 111) of the 146 arguments about e‐cigarette regulation attributed to stakeholders were in favour of regulation. Tables [1](#add13320-tbl-0001){ref-type="table-wrap"} and [2](#add13320-tbl-0002){ref-type="table-wrap"} detail the frequency of support for, and opposition to, specific types of regulation.

###### 

Frequency of arguments against specific regulatory measures by stakeholder category.

                                                           *Health charities*   *E‐cigarette industry*   *Smokers\' rights groups*   *Total*
  ------------------------------------------------------- -------------------- ------------------------ --------------------------- ---------
  Type of regulation                                                                                                                
  Prohibition of e‐cigarettes in enclosed public spaces            4                      2                          1                  7
  Regulation of e‐cigarettes as medicine                           0                      2                          0                  2
  Regulation of marketing, advertising and promotion               0                      0                          1                  1
  Total                                                            4                      4                          2                 10

Fifty‐two arguments about e‐cigarette regulation were not related to any specific measure. Specific measures that stakeholders commented on included regulating: minimum purchasing age (*n* = 25); marketing, advertising and promotion (*n* = 25); the use of e‐cigarettes in enclosed public spaces (*n* = 24); and e‐cigarettes as medicines (*n* = 19). Of the 94 statements associated with specific measures, 84 (90.4%) were supportive and 10 (10.6%) opposed. Supporting information, Tables [\[Link\]](#add13320-supitem-0004){ref-type="supplementary-material"}, [\[Link\]](#add13320-supitem-0005){ref-type="supplementary-material"}, detail the frequencies of stakeholder categories\' uses of different rationales.

A minimum age for purchasing e‐cigarettes was the most frequently supported measure (*n* = 25), associated frequently with child protection (*n* = 13). Tom Rolfe of Skycig welcomed 'any regulations which will help us to ensure that under‐18s cannot access electronic cigarettes' (*Scotsman*, 8 October 2013). Age‐of‐sale restrictions were justified by framing e‐cigarette use as a gateway to tobacco use (*n* = 5); Mark Drakeford of the Welsh Government highlighted the risk of 'a new generation becoming addicted to \[nicotine\]' (*Daily Mail*, 3 April 2014).

Marketing regulations were supported frequently (*n* = 24), and only opposed by Simon Clark of FOREST, who argued that 'e‐cigarettes are increasingly popular with smokers who are trying to cut down or quit \[\...\] and introducing greater restrictions on advertising, could do far more harm than good' (*Scotsman*, 27 June 2014). Protecting children and young people was mentioned frequently (*n* = 20) in statements advocating marketing regulation; Deborah Arnott of ASH warned of children being 'targeted' by e‐cigarette marketing (*Guardian*, 28 April 2014).

Regulating e‐cigarettes as medicine was advocated 17 times and only opposed overtly twice, by ECITA. Support was rationalized by the need to ensure product safety and the potential of e‐cigarettes in tobacco cessation. Health concerns related predominantly to toxicity of e‐cigarette vapour, as well as risks associated with malfunctioning e‐cigarettes and the ingestion of e‐cigarette liquid. Kevin Fenton of Public Health England described the measure as essential to 'assure people of their safety' (*Daily Telegraph*, 26 November 2014). Deborah Arnott argued that the measure would 'ensure \[e‐cigarettes\] are good quality \[\...\] so they can be made available on prescription' (*Observer*, 25 May 2014). Similarly, Dame Sally Davies, England\'s Chief Medical Officer, suggested that if the e‐cigarette vapour content were to be controlled, e‐cigarettes 'might play a useful role in stopping smoking' (*Daily Mail*, 3 April 2014). Criticism of regulating e‐cigarettes as medicine highlighted the burden on small e‐cigarette manufacturers and the comparative benefits to TTCs. Katherine Devlin of ECITA warned that regulation might 'close out all the competition \[...so TTCs...\] could get the whole market share for themselves' (*Daily Mail*, 20 May 2013).

Prohibiting e‐cigarette use in enclosed public spaces was argued for 17 times and opposed seven times. The measure lacked the broad‐ranging support across stakeholder categories that other measures received, and was thus the key area of disagreement between public health stakeholders. Support for the measure was rationalized by citing: the risks associated with exposure to second‐hand vapour; the importance of protecting children; and the risk of re‐normalizing smoking. The WHO questioned the safety of second‐hand e‐cigarette vapour: 'the fact \[e‐cigarette\] exhaled aerosol contains on average lower levels of toxicants than the emissions from combusted tobacco does not mean these levels are acceptable to involuntarily exposed bystanders' (*Sunday* *Herald*, 31 August 2014). Dame Sally Davies cautioned against 'normalising e‐cigarettes' and 'making smoking seem like a normal activity' (*Daily Mail*, 19 May 2014). Dr Ram Moorthy of the BMA warned against reversing progress made towards making smoking 'socially unacceptable' (*Sun*, 22 May 2014).

Rationales used to oppose prohibiting e‐cigarettes in enclosed public spaces included their role in tobacco cessation and the limited evidence of risks. Tom Pruen of ECITA argued that 'being able to use \[e‐cigarettes\] indoors is a big incentive for people to move away from tobacco' (*Sunday* *Herald*, 31 August, 2014). Highlighting the limited evidence base, Neil McKeganey of the Centre for Drug Misuse Research described second‐hand exposure fears as 'theoretical' (*Sunday* *Herald*, 31 August 2014), while Hazel Cheeseman of ASH characterized 'evidence of any harm to bystanders from use of these devices' (*Herald*, 20 August 2014) as absent.

Incomplete evidence of the health risks of e‐cigarettes was cited by stakeholders from a range of categories, and used to support arguments both for and against regulation, indicating that different stakeholders used the inconclusive evidence base differently. Promoting a precautionary approach, John Middleton of the Faculty of Public Health stated that 'We don\'t yet have enough evidence yet \[*sic*\] of the impact \[e‐cigarettes\] are having on other people' (*Daily Mail*, 17 December 2014). Conversely, Charlie Hamshaw‐Thomas of E‐Lites, advocating a harm‐reduction approach, characterized the BMA as '"experts" without evidence playing puppet to the pharmaceutical industry\'s agenda' (*Scotland* *on* *Sunday*, 20 October 2013).

Discussion {#add13320-sec-0011}
==========

We examined UK newsprint representations of the growing e‐cigarette regulation debate, highlighting the stakeholders involved and their stances towards regulation. The research findings are subject to certain limitations. As with most media analyses, the extent to which stakeholders\' actual positions were distorted in media representations is unknown. However, given the impact of media representations on public understandings, media representations are no less important than stakeholders\' true positions. A limitation specific to this study is that a larger sample size, achieved by either a broader sampling frame or longer search period, would have increased the external validity of the findings. Further, as data on citations of stakeholders were collected as simple tallies, we could not investigate trends in representations of stakeholders over time. Future research could analyse media coverage subsequent to 2014 to examine how representations of stakeholders have evolved over time. Additionally, including other forms of media, including social media, may have added depth to understandings of the debate, particularly as e‐cigarette regulation seems to garner considerable engagement online. Despite these limitations, this study makes a valuable contribution to the literature on e‐cigarette regulation [16](#add13320-bib-0016){ref-type="ref"}. By enabling comparison between the e‐cigarette debate and other tobacco control debates, our analysis may inform future advocacy in the United Kingdom and internationally. We suggest that public disagreement between tobacco control advocates may be harmful to shared health policy goals. However, rather than recommending against public debate, we would instead recommend emphasizing the substantial areas of consensus that exist.

Our data illustrate increased newspaper coverage of the e‐cigarette debate throughout 2013 and 2014, and comparison with data on UK newspaper coverage of other health legislation debates indicates that the e‐cigarette regulation debate occupied a similar number of articles as legislation to prohibit smoking in vehicles carrying children [35](#add13320-bib-0035){ref-type="ref"}, but substantially fewer articles than proposed legislation to impose a minimum price per unit of alcohol [28](#add13320-bib-0028){ref-type="ref"}. The sharp rise in reporting on e‐cigarette regulation in late 2014 suggests that the profile of the issue may have continued to rise in 2015.

We found that stakeholders supported e‐cigarette regulation much more frequently than they opposed it, suggesting that the overall tone of media representations of the debate was favourable to regulation. To an extent, this is foreseeable in a debate about potential regulation, as the presence of arguments for regulation is a prerequisite for the presence of opposing arguments. Governments, regulatory bodies, politicians and health charities were broadly aligned in support for regulation of purchasing age, regulation of marketing and regulating e‐cigarettes as medicine, and these measures were rarely opposed. Widespread support for the regulation of e‐cigarettes as medicine is probably founded on a perceived need to set the parameters of what e‐cigarettes and refills may be composed of, both for the protection of consumers, as highlighted in our data, and to ensure a uniform product for which further regulation can be designed. Purchasing age restrictions and regulation of marketing were frequently justified based on the need to protect children from harm, a rationale that industry actors have been unwilling to oppose in past tobacco control debates [36](#add13320-bib-0036){ref-type="ref"}.

Prohibition of e‐cigarette use in enclosed public spaces was the key area of disagreement within and between the most vocal stakeholder groups. While comparable restrictions have been successful when applied to tobacco [37](#add13320-bib-0037){ref-type="ref"}, evidence of the risks of second‐hand vaping is scarce [38](#add13320-bib-0038){ref-type="ref"}, which may go some way to explaining the relative lack of enthusiasm for the measure. Advocates rationalized their support primarily by citing the risks of re‐normalizing smoking behaviours, which are more abstract and perhaps less persuasive than direct health risks. Additionally, those positioning e‐cigarettes as tobacco cessation tools portrayed the prohibition of their use in enclosed public spaces as counterproductive, as it would reduce tobacco smokers\' incentives to adopt the (assumed) safer alternative. The disagreement exhibited by health charities on this issue illustrated the challenge they face in finding balance between the promise and threat of this disruptive technology.

Transnational tobacco companies had a low profile in the media debate in 2013 and 2014, indicating that TTCs' attempted rehabilitation through engagement in harm reduction debates [39](#add13320-bib-0039){ref-type="ref"}, [40](#add13320-bib-0040){ref-type="ref"} is not evident in UK newsprint coverage. Our data cannot explain the near‐absence of TTCs in the debate, but various explanations may be posited: TTCs may have chosen not to draw attention to their growing share of the e‐cigarette market; TTCs may be confident in their financial capacity to adapt to regulation (which could be prohibitively expensive for independent e‐cigarette companies); and TTCs may anticipate that regulation to standardize the nicotine content of e‐cigarettes will encourage profitable dual use of tobacco and e‐cigarettes. Additionally, TTCs may have decided not to reach conclusions ahead of the EU TPD in April 2014, in which case their profile may have risen subsequent to the sample period.

Tobacco control advocates have previously been unified largely around the regulatory measures they support [41](#add13320-bib-0041){ref-type="ref"}, and coalitions and the promotion of unambiguous messages have been instrumental to successful advocacy [42](#add13320-bib-0042){ref-type="ref"}, [43](#add13320-bib-0043){ref-type="ref"}. Our analysis found that public health stakeholders demonstrated less unity in the e‐cigarette regulation debate than in previous tobacco control debates [41](#add13320-bib-0041){ref-type="ref"}, and the two open letters addressed to the WHO by opposing groups of public health and medical experts [41](#add13320-bib-0041){ref-type="ref"} indicate that that disunity exists beyond media representations. The first letter advised the WHO to recognize the harm reduction potential of e‐cigarettes and reverse recommendations for regulation that would suppress their availability, while the second supported the WHO\'s existing precautionary stance on e‐cigarette regulation. Disagreement between public health stakeholders may be explained partially by the absence (prior to October 2014) of official international guidance on the issue, as WHO guidance has been found to have aided consensus‐building in past tobacco control advocacy [43](#add13320-bib-0043){ref-type="ref"}, [44](#add13320-bib-0044){ref-type="ref"}, [45](#add13320-bib-0045){ref-type="ref"}, [46](#add13320-bib-0046){ref-type="ref"}. Variations in stakeholders' positions might also be explained by the incomplete evidence base concerning the harms and benefits of e‐cigarettes, differing starkly from the comprehensive evidence for the harms of tobacco.

Rather than solely attributing disagreements to limited evidence, we suggest that more fundamental barriers to agreement lie in the frameworks within which actors interpret and use that evidence base. Fairchild & Bayer [4](#add13320-bib-0004){ref-type="ref"} argue that differing assessments of e‐cigarettes stem from conflicting philosophical frameworks of public health: harm reduction and precaution. Harm reduction can be described as a pragmatic approach acknowledging that people will inevitably use drugs, and viewing risk minimization as a worthy public health goal, whereas precautionary approaches focus on the complete elimination of harmful habits, arguing that simply reducing harm is undesirable and cautioning against serving the interests of TTCs. The same evidence may be interpreted differently depending on the framework that is applied. Our analysis indicates that stakeholders using rationales commensurate with harm reduction (such as promoting e‐cigarettes as tobacco cessation aids or highlighting the lack of evidence of the risks of e‐cigarettes) tended to oppose the prohibition of e‐cigarette use in enclosed public spaces, while those using precautionary rationales (such as cautioning against the re‐normalization of smoking and the potential role of e‐cigarettes as gateways to tobacco) tended to favour comprehensive regulation. Stakeholders may model their stances towards regulation based on their pre‐existing adherence to a specific framework, but equally these frameworks may be used to post‐rationalize stances towards regulation.

Divisions between public health stakeholders exist within other tobacco control debates [47](#add13320-bib-0047){ref-type="ref"}. For example, some forms of smokeless tobacco are promoted as tobacco cessation aids by some [48](#add13320-bib-0048){ref-type="ref"} and cautioned against by others, who highlight their carcinogenic content, the involvement of TTCs in their production and marketing and the inconclusive evidence of their effectiveness in tobacco cessation [49](#add13320-bib-0049){ref-type="ref"}. Given that conflict within the tobacco control community is neither a new phenomenon nor one that relates exclusively to e‐cigarettes, confronting disagreement is of relevance beyond the e‐cigarette regulation debate. Industry actors with a history of opposing tobacco control legislation could exploit disagreement by characterizing tobacco control regulation as contested. This threat may incentivize public health advocates to develop common ground further and highlight existing agreement to present unified, unambiguous positions.

This paper contributes to the body of literature concerning mass media representations of public health policy and the dynamics of e‐cigarette regulation debates. While public health stakeholders are largely unified in support of e‐cigarette regulation, the disagreement that exists, concerning primarily the regulation of e‐cigarettes in public places, is evident in the public sphere. Given the persuasive power of presenting consistent messages in tobacco control debates, achieving consensus and agreeing on unambiguous advocacy positions on e‐cigarette regulation would probably increase the political effectiveness of the public health community. As public health stakeholders draw from divergent frameworks, reaching consensus is not simply a case of awaiting further research evidence, but one of negotiating shared values concerning how evidence is interpreted and presented. If critical engagement with public health frameworks is impractical, then a more pragmatic goal for the tobacco control community may be to refrain from commenting on contentious aspects of regulation in the public sphere to avoid gifting opponents of tobacco control the opportunity to exploit uncertainty, and focus instead on common areas of agreement. Ongoing debates about e‐cigarette regulation and other tobacco control issues in the United Kingdom and abroad may benefit from incorporating this approach.
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